Synergistic interactions of cyclosporine, rapamycin, and brequinar on heart allograft survival in mice
Stepkowski, S.M.; Tu, Y.; Chou, T.C.; Kahan, B.D.
Transplantation Proceedings 26(5): 3025-3027
1994
ISSN/ISBN: 0041-1345 PMID: 7940952 Document Number: 427444
Document emailed within 1 workday
Related Documents
Ferraresso, M.; Knight, R.; Tu, Y.; Stepkowski, S.M.; Kahan, B.D. 1994: Triple combination of cyclosporine, brequinar, and rapamycin prolongs kidney allograft survival in the mongrel dog Transplantation Proceedings 26(5): 3028Hale, D.A.; Gottschalk, R.; Fukuzaki, T.; Wood, M.L.; Maki, T.; Monaco, A.P. 1997: Superiority of sirolimus (rapamycin) over cyclosporine in augmenting allograft and xenograft survival in mice treated with antilymphocyte serum and donor-specific bone marrow Transplantation 63(3): 359-364
Cosenza, C.A.; Tuso, P.J.; Chapman, F.A.; Middleton, Y.D.; Cramer, D.V.; Wu, G.D.; Makowka, L. 1993: Prolonged xenograft survival following combination therapy with brequinar sodium and cyclosporine Transplantation Proceedings 25(3 Suppl 2: 59-60
Fabian, M.C.; Lakey, J.R.; Rajotte, R.V.; Kneteman, N.M. 1992: Rapamycin prolongs murine islet allograft survival Transplantation Proceedings 24(6): 2842
Wang, M.; Qu, X.; Stepkowski, S.M.; Chou, T.C.; Kahan, B.D. 1996: Beneficial effect of graft perfusion with anti-T cell receptor monoclonal antibodies on survival of small bowel allografts in rat recipients treated with brequinar alone or in combination with cyclosporine and sirolimus Transplantation 61(3): 458-464
Sonoda, K.; Meek, A.G.; Strober, S.; Hayashi, R.; Ishimaru, M.; Rapaport, F.T. 1989: Synergistic efficacy of staged total lymphoid irradiation and cyclosporine in the preoperative preparation of high-risk hyperimmunized canine renal allograft recipients Transplantation Proceedings 21(1 Pt 1): 1116-1117
Tchervenkov, J.I.; Epstein, M.D.; Alexander, J.W.; Schroeder, T.J. 1989: The effect of donor-specific blood transfusion, cyclosporine, and dietary prostaglandin precursors on rat cardiac allograft survival. II. Effectiveness of a 24-hour induction period with DST and CsA in inducing long-term graft survival Transplantation 47(1): 177-181
Black, K.S.; Hewitt, C.W.; Chau, C.L.; Pizzo, L. 1988: Transdermal application of cyclosporine prolongs skin allograft survival Transplantation Proceedings 20(2 Suppl 2: 660-662
Hale, D.A.; Gottschalk, R.; Maki, T.; Monaco, A.P. 1998: Determination of an improved sirolimus (rapamycin)-based regimen for induction of allograft tolerance in mice treated with antilymphocyte serum and donor-specific bone marrow Transplantation 65(4): 473-479
Davies, C.B.; Cofer, B.R.; Alexander, J.W. 1991: Effects of donor-specific transfusion, cyclosporine a and FK 506 on rat cardiac allograft survival Transplantation Proceedings 23(6): 3314-3315
Lenrow, D.A.; Markmann, J.F.; Shachner, M.S.; Naji, A. 1989: Prolongation of cardiac allograft survival by suppressor T cells (Ts) generated in vitro using cyclosporine Transplantation Proceedings 21(1 Part 1): 473-474
Farges, O.; Buffello, D.; Shi, Y.M.; Moufetier, A.; Bismuth, H. 1995: Prolongation of cardiac allograft survival following intraportal injection of donor antigen is inhibited by cyclosporine a Transplantation Proceedings 27(4): 2525-2527
Nakaji, K.; Nakata, T.; Yasumura, T.; Ohmori, Y.; Oka, T.; Takada, K.; Muranishi, S. 1988: Prolongation of rat renal allograft survival by injection of a small dose of cyclosporine into the thoracic duct Transplantation Proceedings 20(2 Suppl 2: 298-300
Hoshino, Y.; Suzuki, C.; Ohtsuki, M.; Masubuchi, Y.; Amano, Y.; Chiba, K. 1996: FTY720, a novel immunosuppressant possessing unique mechanisms. II. Long-term graft survival induction in rat heterotopic cardiac allografts and synergistic effect in combination with cyclosporine a Transplantation Proceedings 28(2): 1060-1061
Han, W.R.; Zhan, Y.; Murray-Segal, L.J.; Brady, J.L.; Lew, A.M.; Mottram, P.L. 2000: Prolonged allograft survival in anti-CD4 antibody transgenic mice: lack of residual helper T cells compared with other CD4-deficient mice Transplantation 70(1): 168-174
Choti, M.; Lenrow, D.; Roza, A.; Markmann, J.; Naji, A. 1989: Prolongation of cardiac allograft survival by pretransplant administration of cyclosporine and donor-specific dendritic cells Transplantation Proceedings 21(1 Pt 1): 478-479
Hale, D.A.; Gottschalk, R.; Fukuzaki, T.; Wood, M.L.; Maki, T.; Monaco, A.P. 1996: Extended skin allo- and xenograft survival in mice treated with rapamycin, antilymphocyte serum, and donor-specific bone marrow transfusion Transplantation Proceedings 28(6): 3269
Militerno, G.; Gugenheim, J.; Cuomo, O.; Hofman, P.; Mouiel, J.; Tovey, M. 1994: Synergistic interaction between anti-IFN alpha/beta antibody and low doses of cyclosporine therapy prolongs heart transplants in rats Transplantation Proceedings 26(5): 3050-3051
Ueda, K.; Baumgartner, W.A.; Beschorner, W.E.; Borkon, M.A.; Soule, L.M.; Reitz, B.R.; Herskowitz, A. 1985: Histologic pattern of early heart allograft rejection under cyclosporine treatment Journal of Heart Transplantation 4(3): 296-301
Abbud-Filho, M.; Kupiec-Weglinski, J.W.; Araujo, J.L.; Heidecke, C.D.; Tilney, N.L.; Strom, T.B. 1984: Cyclosporine therapy of rat heart allograft recipients and release of interleukins (IL 1, IL 2, IL 3): a role for IL 3 in graft tolerance? Journal of Immunology 133(5): 2582-2586